Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOPOTECAN vs TORIPALIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOPOTECAN vs TORIPALIMAB: Safety Overview

Metric TOPOTECAN TORIPALIMAB
Total FAERS Reports 3,537 1,344
Deaths Reported 773 65
Death Rate 21.9% 4.8%
Hospitalizations 1,213 823
Average Patient Age 28.7 yrs 58.0 yrs
% Female Patients 51.1% 24.9%
FDA Approval Date Aug 28, 2012 N/A
Manufacturer Sandoz Inc Coherus Oncology, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A